Medtech industry, lawmakers concerned about FDA's 510(k) proposals
This article was originally published in Clinica
Executive Summary
The cumulative effect of preliminary proposals by the US FDA to overhaul its 510(k), process for clearing medical devices could adversely affect the agency's ability to effectively carry out "mission-critical" functions, including timely reviews, industry has warned.